- Service Name
Intellia Therapeutics
- Industry
Biotechnology, Healthcare, Gene Editing, Therapeutics
- Main Value Proposition
Transforming lives of people with severe diseases by developing innovative genome editing treatments.
- Description
Intellia Therapeutics is a clinical-stage genome editing company focused on developing potentially curative therapeutics using CRISPR-based technologies. Their mission is to transform the lives of people with severe diseases through innovative gene-editing treatments.
- Key Features
Development of potentially curative genome editing treatments; Utilization of CRISPR-based technologies; Focus on severe diseases; Patient-centric approach with real-life stories
- Use Cases
The service is most valuable for patients suffering from severe genetic diseases, healthcare providers looking for advanced treatment options, and researchers in the field of genome editing.
- Competitive advantages
Leading position in clinical-stage genome editing; Innovative use of CRISPR technology; Strong focus on patient outcomes and real-life impact
- Strengths
Intellia Therapeutics has a strong commitment to innovation in gene editing, a clear mission to improve patient lives, and a robust pipeline of clinical trials aimed at addressing severe diseases.
- Positioning
Intellia Therapeutics positions itself as a pioneer in the genome editing industry, focusing on developing groundbreaking treatments that can potentially cure severe diseases.
- Audience
The target users include patients with severe diseases, healthcare professionals, and investors interested in innovative biotechnologies.
- CTA
Join Us
- Tags
Genome Editing
CRISPR
Therapeutics
Patient Stories
- Tagline
Aiming to make the impossible, possible
- Tone of Voice
Innovative, compassionate, authoritative
- Differentiation
Intellia Therapeutics stands out in the market by leveraging advanced CRISPR technology to create potentially curative treatments, focusing on severe and rare diseases that have limited treatment options.
- Brand Positioning
The brand identity of Intellia Therapeutics is centered around innovation, hope, and a commitment to transforming healthcare through advanced gene editing technologies.
- Founded
2014-01-01
- Founders
Andy May
Derrick Rossi
Erik Sontheimer
Jennifer Doudna
Luciano Marraffini
Nessan Bermingham
Rodolphe Barrangou